“Although lymphangioleiomyomatosis [LAM] is a rare condition, many pulmonary physicians will encounter it at some point in their careers, and it is important for the community to have the tools to properly diagnose and manage the disease,” said Francis McCormack, MD, University of Cincinnati Taylor Professor and director, division of pulmonary, critical care and sleep
Home spirometry is being added as a secondary end point in a lymphangioleiomyomatosis (LAM) trial soon to begin enrollment at the University of Cincinnati (UC) Medical Center. Its inclusion is aimed at helping to assess the feasibility and reliability of performing home spirometry among patients with LAM. “Checking lung function more often will result in
“A strategy of performing high-resolution computed tomography [HRCT] scanning followed by pleurodesis is cost-effective in screening for the presence of diffuse cystic lung diseases (DCLDs) in patients who present with an apparent primary spontaneous pneumothorax (PSP),” said Nishant Gupta, MD, assistant professor of medicine and director of the Interstitial Lung Diseases Center, University of Cincinnati
“Most of us were taught that magnetic resonance imaging (MRI) is not useful for studying the pulmonary parenchyma; but that is changing,” says Frank McCormack, MD. Jason Woods, PhD, agrees that use of MRI in pulmonary disease is coming of age, as clinicians learn that novel MRI approaches can provide risk-free high resolution images of
